Advanced Medical Isotope (RDGL)
(Delayed Data from OTC)
$0.13 USD
0.00 (3.08%)
Updated Aug 30, 2024 12:04 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
RDGL 0.13 0.00(3.08%)
Will RDGL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RDGL based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for RDGL
Pineapple Financial And 1 Other Stock Under $1 Insiders Are Buying
Vivos Inc. Provides IDE Submission Status Update ? Conversion to Pre-Sub Filing Accepted by the FDA
Vivos Inc. Submits the Application to the FDA for Authority to Initiate Human Clinical Trials
Alset And 2 Other Stocks Under $2 Insiders Are Buying